Patent Foramen Ovale Closure with the AMPLATZER PFO OCCLUDER in Patients with Recurrent Cryprogenic Stroke Due to Presumed Paradoxical Embolism through a Patent Foramen Ovale Who Have Failed Conventional Drug Therapy (PFO ACCESS Registry)

Submitted by centretek on Sat, 10/15/2022 - 10:29
Source URL
https://www.inova.org/clinical-trials/patent-foramen-ovale-closure-amplatzer-pfo-occluder-patients-recurrent-cryprogenic
Description
General Information Age Group Adults Status Active Protocol Number N/A Offered At Inova Heart and Vascular Institute 3300 Gallows Road Falls Church, VA  22042 Principal Investigator James Thompson, MD Eligibility Information Patients ≥18 years old Patients with a PFO who have already experienced at least two cryptogenic strokes due to presumed paradoxical embolism through a patent foramen ovale Patients who have failed conventional drug therapy Contact Information Contact Name Sally Keyte Contact Phone 703-776-2995 Contact Email Send Email
Clinical Trials Category
Heart
Clinical Trials Sub categories
Pediatric and Adult Congenital Interventional Cardiology
Crawled Content Type
Clinical Trials
Age Group
Adults
is_synonym
Off
Also a children's page
Off